Literature DB >> 14571080

Development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor.

Teruki Dainichi, Maya Tanaka, Nobuko Tsuruta, Masutaka Furue, Keishi Noda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14571080     DOI： 10.1159/000073100

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  6 in total

1.  Paronychia and Periungual Granulation as a Novel Side Effect of Ibrutinib: A Case Report.

Authors:  Ahu Yorulmaz; Basak Yalcin
Journal:  Skin Appendage Disord       Date:  2019-10-08

2.  A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.

Authors:  Kara D Capriotti; Milan Anadkat; Jennifer Choi; Benjamin Kaffenberger; Beth McLellan; Samuel Barone; Oluwaseun Kukoyi; Shari Goldfarb; Mario Lacouture
Journal:  Invest New Drugs       Date:  2019-06-26       Impact factor: 3.850

3.  Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

Authors:  M Fakih; M Vincent
Journal:  Curr Oncol       Date:  2010-07       Impact factor: 3.677

4.  Panitumumab-Induced Paronychia: A Case Report and a Brief Review of the Literature.

Authors:  Ahu Yorulmaz; Basak Yalcin
Journal:  Skin Appendage Disord       Date:  2020-12-03

Review 5.  Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management.

Authors:  K Chanprapaph; V Vachiramon; P Rattanakaemakorn
Journal:  Dermatol Res Pract       Date:  2014-03-02

6.  Multifocal periungual granulation tissue related to ibrutinib therapy.

Authors:  Aatman Shah; Anneli Bowen; Christopher Hansen
Journal:  JAAD Case Rep       Date:  2020-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.